Creative Diagnostics Supports COVID-19 Testing with Antigen Lateral Flow Assay Development

As a global leading supplier of of raw materials, antibodies, and reagents for bio-technology industry, Creative Diagnostics now introduces COVID-19 Antigen Lateral Flow Assay Development, including the SARS-CoV-2 nucleoprotein antibody pair for rapid COVID-19 antigen assays to equip healthcare workers for rapid COVID-19 antigen detection. Additionally, Creative Diagnostics also offers SARS-CoV-2 antigen extraction buffer tubes that can be used as packing supplies for SARS-CoV-2 antigen extraction.

The global COVID-19 pandemic has created an urgent demand for accurate rapid point of care testing. Antigen-based assays are suitably inexpensive and can be rapidly mass-produced, but sufficiently accurate performance requires highly optimized antibodies and assay conditions. Creative Diagnostics team has tested hundreds of anti-nucleocapsid antibody pairs to recommend clients the best pair for further development of an LFA for SARS-CoV-2 Antigen.

SARS-CoV-2 antigen extraction buffer tubes are also designed by Creative Diagnostics experts to extract SARS-CoV-2 antigen from nasopharyngeal swab, which can be used as packing supplies for SARS-CoV-2 Rapid Antigen test development and production. It's noted that the slim tube design of these plastic tubes also reduces the need for the amount of extraction buffer, thereby increasing the concentration of the virus antigen in the sample and improving the positive detection rate of virus antigen.

"To better response to the pandemic, Creative Diagnostics remains focused on its mission to serve the life science community to achieve their mission faster. We'll continue to expand our COVID-19 test portfolio, and increase our accurate, convenient diagnostic testing offerings to help global scientists to address the growing COVID-19 threat." said Dr. Jessica Waldorf, chief scientific officer of R&D department of Creative Diagnostics.

"We know that many scientists are still diligently pursuing their research, particularly those focused on COVID-19, and to meet their growing needs, we've provided a series of additional SARS-CoV-2 related products and services to ensure that our customers have the supplies they need to continue their research programs. We are proud to support them in these efforts." said Prof. Mike Knuth, M.D., the chief scientific officer of R&D department of Creative Diagnostics.

If you want to know more information about SARS-CoV-2 related testing products or other coronavirus research materials, please contact Creative Diagnostics at 1-631-619-7922 or email to contact@creative-diagnostics.com.

About Creative Diagnostics

Creative Diagnostics is a leading manufacturer and supplier of antibodies, viral antigens, innovative diagnostic components and critical assay reagents. It also provides contract biologic R&D and manufacturing services to the diagnostic manufacturers along with GMP biologics manufacturing for the biopharmaceutical market. It aims to provide a trusted source for all researchers' assay development and manufacturing needs.